FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079253 [Registered on: 23/01/2025] Trial Registered Prospectively
Last Modified On: 23/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Analgesic efficacy of intraperitoneal instillation of dexamethasone and bupivacaine versus bupivacaine in patient undergoing laparoscopic cholecystectomy. 
Scientific Title of Study   Analgesic efficacy of intraperitoneal instillation of dexamethasone and bupivacaine versus bupivacaine in patient undergoing laparoscopic cholecystectomy.  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prachi Kamble 
Designation  Junior Resident 
Affiliation  Datta Meghe Institute of Medical Science and research 
Address  Department of Anaesthesiology,Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  9594095760  
Fax    
Email  kambleprachi022@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Neeta Chaudhary Verma 
Designation  Professor 
Affiliation  Datta Meghe Institute of Medical Science and research 
Address  Department of Anaesthesiology,Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  8788378382  
Fax    
Email  neetachaudhary1234@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Neeta Chaudhary Verma 
Designation  Professor 
Affiliation  Datta Meghe Institute of Medical Science and research 
Address  Department of Anaesthesiology,Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha

Wardha
MAHARASHTRA
442001
India 
Phone  8788378382  
Fax    
Email  neetachaudhary1234@gmail.com  
 
Source of Monetary or Material Support  
Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha, 442001  
 
Primary Sponsor  
Name  JNMC 
Address  Sawangi Meghe, Wardha, Maharashtra, India 442001 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prachi Kamble  Jawaharlal Nehru Medical College  Department of Anaesthesiology, Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha Wardha MAHARASHTRA
Wardha
MAHARASHTRA 
9594095760

kambleprachi022@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Datta Meghe Institute of Higher Education and Research (Deemed to be University)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K800||Calculus of gallbladder with acutecholecystitis, (2) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  bupivacaine  Bupivacaine is the potent local anaesthetic drug. which is commonly used in giving blocks and in regional anaesthesia.inj bupivacaine will be given 0.25% 40ml alone without other adjuvant drug. 
Intervention  DEXAMETHASONE AND BUPIVACAINE  Dexamethsone is the corticosteroids. it is commonly used in inflammatory conditions.Bupivacaine is a potent local anethesia drug. Hence in the study bupivacaine 0.25% 40 ml with 12mg dexamethsone will be used intraoperatively and will be given intraperitoneally 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients willing to participate in the study
ASA grade one to two.
Patients undergoing laparoscopic cholecystectomy 
 
ExclusionCriteria 
Details  Patients of age group less than eighteen years and above sixty years.
ASA grade three to four.
Patients with history of Diabetes mellitus.
Patient allergic to the study drug.
Pregnant females.
Patients with history of previous abdominal surgeries.
laparoscopic cholecystectomy got converted to open
cholecystectomy.
Patients on steroids. 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
patient receiving dexamethasone 12mg along with bupivacaine 0.25% 4o ml had a significantly longer duration of analgesia  Pre operatively and post operatively - baseline, 1 hourly, 2 hourly, 4 hourly, 8 hourly, 12 hourly, 16 hourly, 24 hourly 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the time of the first rescue.
To compare the time to total rescue analgesic done.
To study the post operative nausea,vomiting, hypergycemia and any adverse effect among the group. 
24 hrs 
 
Target Sample Size   Total Sample Size="110"
Sample Size from India="110" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   03/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   After selecting patients on the basis of the inclusion and exclusion criteria posted electively for laparoscopic cholecystectomy will be given Intraperitoneal instillation of injection Dexamethsone 12mg with 0.25% injection Bupivacaine 40ml  is expected to significantly reduces post operative pain and requirment of rescue analgesic compared to 0.25% injection Bupivacaine 40ml alone.  
Close